1. Sharbafchi MR, Rajabi F, Haghshenas A, Motamedi N, Mousavi SZ. Evaluation of depression, anxiety, and stress among unrelated kidney donors [in Persian]. J Isfahan Med Sch 2018; 35(464): 1962-8.
2. Rezaeimehr MR, Zargham M, Jahanabadi Z, Afsar F, Rahnama'i MS, Sharbafchi MR, et al. Association between lower urinary tract symptoms (LUTS) and obsessive‐compulsive disorders (OCD) in women: a study based on urodynamic findings and micturition problem. Neurourol Urodyn 2022; 41(1): 357-64.
3. Lei S-Y, Qu Y, Yang Y-Q, Liu J-C, Zhang Y-F, Zhou S-Y, et al. Cellular senescence: A novel therapeutic target for central nervous system diseases. Biomed Pharmacother 2024; 179: 117311.
4. Lardelli M, Baer L, Hin N, Allen A, Pederson SM, Barthelson K. The use of zebrafish in transcriptome analysis of the early effects of mutations causing early onset familial Alzheimer’s disease and other inherited neurodegenerative conditions. J Alzheimers Dis 2024; 99(s2): S367-S81.
5. Caldarelli M, Rio P, Marrone A, Ocarino F, Chiantore M, Candelli M, et al. Gut–Brain Axis: Focus on Sex Differences in Neuroinflammation. Int J Mol Sci 2024; 25(10): 5377.
6. Wang J, Wang X, Zhuo E, Chen B, Chan S. Gut‑liver axis in liver disease: From basic science to clinical treatment. Mol Med Rep 2024; 31(1): 10.
7. Li J, Shi B, Ren X, Hu J, Li Y, He S, et al. Lung-intestinal axis, shuangshen granules attenuate lung metastasis by regulating the intestinal microbiota and related metabolites. Phytomedicine 2024; 132: 155831.
8. Yu D, Shen J, Li L, Long Q, Xie S, Zhou M, et al. Investigating the biological significance of the TCM principle “promoting urination to regulate bowel movements” through the influence of the intestinal microbiota and their metabolites on the renal-intestinal axis. Front Cell Infect Microbiol 2025; 14: 1523708.
9. Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 2024; 9(1): 37.
10. Liu T, Du D, Zhao R, Xie Q, Dong Z. Gut microbes influence the development of central nervous system disorders through epigenetic inheritance. Microbiol Res 2023; 274: 127440.
11. Sharbafchi MR, Tabatabaiyan S, Haghighatdoost F, Afshar H, Keshteli AH, Feizi A, et al. Personality traits are related to functional dyspepsia in a large sample of Iranian adults. J Psychosom Re 2020; 129: 109912.
12. Arifuzzaman M, Collins N, Guo C-J, Artis D. Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation. Immunity 2024; 57(1): 14-27.
13. Fang H, Wang Y, Deng J, Zhang H, Wu Q, He L, et al. Sepsis-induced gut dysbiosis mediates the susceptibility to sepsis-associated encephalopathy in mice. mSystems 2022; 7(3): e01399-21.
14. Zhang M-L, Li W-X, Wang X-Y, Wu Y-L, Chen X-F, Zhang H, et al. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption. Front Cell Infect Microbiol 2023; 12: 1095053.
15. Browning KN, Travagli RA. Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol 2014; 4(4): 1339-68.
16. Tiwari S, Paramanik V. Role of probiotics in depression: connecting dots of gut-brain-axis through hypothalamic-pituitary adrenal axis and tryptophan/kynurenic pathway involving indoleamine-2, 3-dioxygenase. Mol Neurobiol 2025; 62(6): 7230-41.
17. Mi N, Ma L, Li X, Fu J, Bu X, Liu F, et al. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids. Open Med (Wars) 2023; 18(1): 20230849.
18. Xiong L, Yao X, Pei J, Wang X, Guo S, Cao M, et al. Do microbial-gut-muscle mediated by SCFAs, microbial-gut-brain axis mediated by insulin simultaneously regulate yak IMF deposition? Int J Biol Macromol 2024; 257(Pt 1):128632.
19. Cui W, Guo Z, Chen X, Yan R, Ma W, Yang X, et al. Targeting modulation of intestinal flora through oral route by an antimicrobial nucleic acid-loaded exosome-like nanovesicles to improve Parkinson’s disease. Sci Bull (Beijing) 2024; 69(24): 3925-35.
20. Kraimi N, Ross T, Pujo J, De Palma G. The gut microbiome in disorders of gut–brain interaction. Gut Microbes 2024; 16(1): 2360233.
21. Marques de Souza PR, Keenan CM, Wallace LE, Habibyan YB, Davoli-Ferreira M, Ohland C, et al. T cells regulate intestinal motility and shape enteric neuronal responses to intestinal microbiota. Gut Microbes 2025; 17(1): 2442528.
22. Ganz J, Ratcliffe EM. Who’s talking to whom: microbiome-enteric nervous system interactions in early life. Am J Physiol Gastrointest Liver Physiol 2023; 324(3): G196-G206.
23. Zhou B, Feng C, Sun S, Chen X, Zhuansun D, Wang D, et al. Identification of signaling pathways that specify a subset of migrating enteric neural crest cells at the wavefront in mouse embryos. Dev Cell 2024; 59(13): 1689-706. e8.
24. Geng Z-H, Zhu Y, Chen W-F, Fu P-Y, Xu J-Q, Wang T-Y, et al. The role of type II esophageal microbiota in achalasia: Activation of macrophages and degeneration of myenteric neurons. Microbiol Res 2023; 276: 127470.
25. Su Y, Cui Z, Yang X, Jiang Y, Zhang W, Zhang Y, et al. Lactobacillus paracasei JY062 and its exopolysaccharide enhance the intestinal barrier through macrophage polarization and Th17/Treg cell balance. Food Res Int 2024; 197(Pt 1): 115235.
26. Zeng H, Jiang Y, Yin Q, Li X, Xiong Y, Li B, et al. Sinisan alleviates stress-induced intestinal dysfunction and depressive-like behaviors in mice with irritable bowel syndrome by enhancing the intestinal barrier and modulating central 5-hydroxytryptamine. Int J Mol Sci 2024;2 5(19): 10262.
27. Sanidad KZ, Rager SL, Carrow HC, Ananthanarayanan A, Callaghan R, Hart LR, et al. Gut bacteria–derived serotonin promotes immune tolerance in early life. Sci Immunol 2024; 9(93): eadj4775.
28. Lu Y, Zhang Z, Tong L, Zhou X, Liang X, Yi H, et al. Mechanisms underlying the promotion of 5‐hydroxytryptamine secretion in enterochromaffin cells of constipation mice by Bifidobacterium and Lactobacillus. Neurogastroenterol Motil 2021; 33(7): e14082.
29. Olivo-Martínez Y, Martínez-Ruiz S, Cordero-Alday C, Bosch M, Badia J, Baldoma L. Modulation of serotonin-related genes by extracellular vesicles of the probiotic Escherichia coli Nissle 1917 in the interleukin-1β-induced inflammation model of intestinal epithelial cells. Int J Mol Sci 2024; 25(10): 5338.
30. Pan M, Qian C, Huo S, Wu Y, Zhao X, Ying Y, et al. Gut-derived lactic acid enhances tryptophan to 5-hydroxytryptamine in regulation of anxiety via Akkermansia muciniphila. Gut Microbes 2025; 17(1): 2447834.
31. Ala M. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Int Rev Immunol 2022; 41(3): 326-45.
32. Tsai W-H, Yeh W-L, Chou C-H, Wu C-L, Lai C-H, Yeh Y-T, et al. Suppressive effects of Lactobacillus on depression through regulating the gut microbiota and metabolites in C57BL/6J mice induced by ampicillin. Biomedicines 2023; 11(4): 1068.
33. Shimizu F, Nakamori M. Blood–Brain barrier disruption in neuroimmunological disease. Int J Mol Sci 2024; 25(19): 10625.
34. Macpherson AJ, Pachnis V, Prinz M. Boundaries and integration between microbiota, the nervous system, and immunity. Immunity 2023; 56(8): 1712-26.
35. Bobba PS, Weber CF, Malhotra A, Bahtiyar MO, Copel J, Taylor SN, et al. Early brain microstructural development among preterm infants requiring caesarean section versus those delivered vaginally. Sci Rep 2023; 13(1): 21514.
36. Bayat A, Safari F, Ghasemi Tehrani H, Doudi M. A review of the role of the female reproductive tract microbiome in reproductive health [in Persian]. J Isfahan Med Sch 2025; 43(828): 1027-43.
37. Zhou L, Qiu W, Wang J, Zhao A, Zhou C, Sun T, et al. Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: a blinded randomized controlled trial. Cell Host Microbe 2023; 31(7): 1232-47. e5.
38. Bayat A, Doudi M, Ahadi AM, Tehrani HG. Isolation and Characterization of Streptococcus agalactiae and its Capsular Antigen, Along with Mycoplasma hominis and Listeria monocytogenes, as Abundant Infections in Women with Abortion in Iran. Jundishapur J Microbiol. 2023; 16(10): e141748.
39. Bayat A, Ghasemi Tehrani H, Doudi M, Ahadi AM. The frequency of streptococcus agalactiae in the vaginal secretions of women with abortion at gynecology and infertility medical centers in Isfahan City [in Persian]. J Isfahan Med Sch 2024; 41(746): 1074-66.
40. Guo S, Huang K, Liu R, Sun J, Yin C. Regulation of gut microbiota through breast milk feeding benefits language and cognitive development of preterm toddlers. Microorganisms 2023; 11(4): 866.
41. Wang M, Ma Y, Zeng B, Yang W, Huang C, Tang B. Influence of the gut microbiota, metabolism and environment on neuropsychiatric disorders. Current Reviews in Clinical and Experimental Pharmacology. 2024; 20(4): 334-48 .
42. Babak A, Shamsaee S, Sharbafchi MR, Khalilinejad-Motlagh R, Ebrahimi P. The relationship between psychological disorders and diabetes mellitus in middle-aged women, Isfahan, Iran, 2015 to 2016 [in Persian]. J Isfahan Med Sch 2019; 37(538): 937-42.
43. Awe T, Fasawe A, Sawe C, Ogunware A, Jamiu AT, Allen M. The modulatory role of gut microbiota on host behavior: exploring the interaction between the brain-gut axis and the neuroendocrine system. AIMS Neurosci 2024; 11(1): 49-62.
44. Zinkow A, Grodzicki W, Czerwińska M, Dziendzikowska K. Molecular Mechanisms Linking Omega-3 Fatty Acids and the Gut–Brain Axis. Molecules 2024; 30(1): 71.
45. Hao Z, Meng C, Li L, Feng S, Zhu Y, Yang J, et al. Positive mood-related gut microbiota in a long-term closed environment: A multiomics study based on the “Lunar Palace 365” experiment. Microbiome 2023; 11(1): 88.
46. Conn KA, Borsom EM, Cope EK. Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease. Gut Microbes 2024; 16(1): 2371950.
47. Wang T, Kuang W, Chen W, Xu W, Zhang L, Li Y, et al. A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia. Alzheimers Res Ther 2020; 12(1): 110.
48. Yılmaz C, Gökmen V. Neuroactive compounds in foods: Occurrence, mechanism and potential health effects. Food Res Int 2020; 128: 108744.
49. Yamout B, Al-Jumah M, Sahraian M, Almalik Y, Al Khaburi J, Shalaby N, et al. Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines. Mult Scler Relat Disord 2024; 83: 105435.
50. Nouri M, Bredberg A, Weström B, Lavasani S. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PloS One 2014; 9(9): e106335.
51. van den Bosch AM, Hümmert S, Steyer A, Ruhwedel T, Hamann J, Smolders J, et al. Ultrastructural axon–myelin unit alterations in multiple sclerosis correlate with inflammation. Ann Neurol 2023; 93(4): 856-70.
52. Tejada‐Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross‐reactivity with myelin basic protein and human herpesvirus‐6 in multiple sclerosis. Ann Neurol 2003; 53(2): 189-97.
53. Wang X, Eguchi A, Yang Y, Chang L, Wan X, Shan J, et al. Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain. Neurobiol Dis 2023; 176: 105951.
54. Hirota T, King BH. Autism spectrum disorder: a review. JAMA 2023; 329(2): 157-68.
55. Wegiel J, Chadman K, London E, Wisniewski T, Wegiel J. Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder. Autism Res 2024; 17(7): 1300-21.
56. Iglesias-Vázquez L, Van Ginkel Riba G, Arija V, Canals J. Composition of gut microbiota in children with autism spectrum disorder: a systematic review and meta-analysis. Nutrients 2020; 12(3): 792.
57. Andreo-Martínez P, Rubio-Aparicio M, Sánchez-Meca J, Veas A, Martínez-González AE. A meta-analysis of gut microbiota in children with autism. J Autism Dev Disord 2022; 52(3): 1374-87.
58. Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation. J Neuroinflammation 2023; 20(1): 165.
59. Shukla PK, Delotterie DF, Xiao J, Pierre JF, Rao R, McDonald MP, et al. Alterations in the gut-microbial-inflammasome-brain axis in a mouse model of Alzheimer’s disease. Cells 2021; 10(4): 779.
60. Ueda A, Shinkai S, Shiroma H, Taniguchi Y, Tsuchida S, Kariya T, et al. Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer’s-type dementia. Cell Rep Med 2021; 2(9): 100398.
61. Ochoa-Repáraz J, Ramelow CC, Kasper LH. A gut feeling: the importance of the intestinal microbiota in psychiatric disorders. Front Immunol 2020; 11: 510113.
62. Wallen ZD, Demirkan A, Twa G, Cohen G, Dean MN, Standaert DG, et al. Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun 2022; 13(1): 6958.
63. Hanscom M, Loane DJ, Shea-Donohue T. Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury. J Clin Invest 2021; 131(12): e143777.
64. Riva N, Domi T, Pozzi L, Lunetta C, Schito P, Spinelli EG, et al. Update on recent advances in amyotrophic lateral sclerosis. J Neurol 2024; 271(7): 4693-723.
65. Chen S, Cai X, Lao L, Wang Y, Su H, Sun H. Brain-gut-microbiota axis in amyotrophic lateral sclerosis: A historical overview and future directions. Aging Dis 2024; 15(1): 74-95.
66. Niccolai E, Di Gloria L, Trolese MC, Fabbrizio P, Baldi S, Nannini G, et al. Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice. Acta Neuropathol Commun 2024; 12(1): 174.
67. Saade J, Mestre TA. Huntington’s disease: latest frontiers in therapeutics. Curr Neurol Neurosci Rep 2024; 24(8): 255-64.
68. Gubert C, Choo JM, Love CJ, Kodikara S, Masson BA, Liew JJ, et al. Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington’s disease mice. Brain Communications 2022; 4(4): fcac205.
69. Wilde J, Slack E, Foster KR. Host control of the microbiome: mechanisms, evolution, and disease. Science 2024; 385(6706): eadi3338.
70. Sugiyama Y, Murayama K. Acute encephalopathy caused by inherited metabolic diseases. J J Clin Med 2023; 12(11): 3797.
71. Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther 2023; 114(1): 51-68.
72. Mouat JS, LaSalle JM. The promise of DNA methylation in understanding multigenerational factors in autism spectrum disorders. Front Genet 2022; 13: 831221.
73. Inchingolo F, Inchingolo AD, Palumbo I, Trilli I, Guglielmo M, Mancini A, et al. The impact of cesarean section delivery on intestinal microbiota: mechanisms, consequences, and perspectives—a systematic review. Int J Mol Sci 2024; 25(2): 1055.
74. Lin J, Xu Y, Guo P, Chen Y-J, Zhou J, Xia M, et al. CCL5/CCR5-mediated peripheral inflammation exacerbates blood‒brain barrier disruption after intracerebral hemorrhage in mice. J Transl Med 2023; 21(1): 196.
75. Moore J, Navarro S, McCarthy K, Rashid RB, Phipps S, Amoako A, et al. State of the art: Intrapartum antibiotics in cesarean section, the infant microbiota and allergic diseases. Acta Obstet Gynecol Scand 2023; 102(7): 811-20.
76. Holmberg SM, Feeney RH, Prasoodanan PK V, Puértolas-Balint F, Singh DK, Wongkuna S, et al. The gut commensal Blautia maintains colonic mucus function under low-fiber consumption through secretion of short-chain fatty acids. Nat Commun 2024; 15(1): 3502.
77. Zhang S, Wang X, Liu S, Hu C, Meng Y. Phlorizin ameliorates cognitive and behavioral impairments via the microbiota-gut-brain axis in high-fat and high-fructose diet-induced obese male mice. Brain Behav Immun 2025; 123: 193-210.
78. Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, et al. High-fat diet alters gut microbiota physiology in mice. ISME J 2014; 8(2): 295-308.
79. Bascuñán KA, Araya M, Rodríguez JM, Roncoroni L, Elli L, Alvarez JDPL, et al. Interplay of n-3 polyunsaturated fatty acids, intestinal inflammation, and gut microbiota in celiac disease pathogenesis. Nutrients 2025; 17(4): 621.
80. Fishbein SR, Mahmud B, Dantas G. Antibiotic perturbations to the gut microbiome. Nat Rev Microbiol 2023; 21(12): 772-88.
81. Vicentini FA, Keenan CM, Wallace LE, Woods C, Cavin J-B, Flockton AR, et al. Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome 2021; 9(1): 210.
82. Sharbafchi MR, Heydari M. Management of substance use disorder in military services: a comprehensive approach. Adv Biomed Res 2017; 6(1): 122.
83. Jiang Y, Qu Y, Shi L, Ou M, Du Z, Zhou Z, et al. The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder. Transl Psychiatry 2024; 14(1): 493.
84. Kiecka A, Szczepanik M. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics. Pharmacol Rep 2023; 75(4): 791-804.
85. Puljiz Z, Kumric M, Vrdoljak J, Martinovic D, Ticinovic Kurir T, Krnic MO, et al. Obesity, gut microbiota, and metabolome: from pathophysiology to nutritional interventions. Nutrients 2023; 15(10): 2236.
86. Yin X-Q, An Y-X, Yu C-G, Ke J, Zhao D, Yu K. The association between fecal short-chain fatty acids, gut microbiota, and visceral fat in monozygotic twin pairs. Diabetes Metab Syndr Obes 2022; 15: 359-68.
87. Cai Y, Deng W, Yang Q, Pan G, Liang Z, Yang X, et al. High-fat diet-induced obesity causes intestinal Th17/Treg imbalance that impairs the intestinal barrier and aggravates anxiety-like behavior in mice. Int Immunopharmacol 2024; 130: 111783.
88. Xu J, Lu Y. The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies. Front Microbiol 2025; 16: 1583562.
89. Sharbafchi MR, Rajabi F, Sheshboluki F, Ghaderi S, Fayazi M, Mousavi SZ. The effect of educational sessions for couples on quality of life among patients with breast cancer undergoing mastectomy [in Persian]. J Isfahan Med Sch 2019; 37(513): 1-8.
90. Ames SR, Lotoski LC, Azad MB. Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation. Gut Microbes 2023; 15(1): 2190305.
91. Baucells BJ, Sebastiani G, Herrero-Aizpurua L, Andreu-Fernández V, Navarro-Tapia E, García-Algar O, et al. Effectiveness of a probiotic combination on the neurodevelopment of the very premature infant. Sci Rep 2023; 13(1): 10344.
92. Herrero-Aizpurua L, Andreu-Fernández V, Navarro-Tapia E, García-Algar O, Figueras-Aloy J. Effectiveness of a probiotic combination on the neurodevelopment of the very premature infant. Sci Rep 2023; 13(1): 10344.
93. Tong Y, Lu G, Guo J, Liu M, Dai Y, Zhang J, et al. A New Intestinal Supplement Synbiotics Therapeutically Regulates Gut Microbiota and Activates Ppars Pathway to Inhibit Alzheimer’s Disease Progression in Mouse Models. New Microbiol 2024; 47(1): 68-79.
94. Yadegar A, Bar-Yoseph H, Monaghan TM, Pakpour S, Severino A, Kuijper EJ, et al. Fecal microbiota transplantation: current challenges and future landscapes. Clin Microbiol Rev 2024; 37(2): e00060-22.
95. Zhang X, Tang B, Guo J. Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener 2023; 12(1): 59.
96. Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, Ye S, Ye K, Wei D, Song Z, Chen D. Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice. Transl Psychiatry 2019; 9(1): 189.
97. Kunnummal SP, Khan M. Diet–gut microbiome interaction and ferulic acid bioavailability: Implications on neurodegenerative disorders. Eur J Nutr 2024; 63(1): 51-66.
98. Chu H, Huang C, Xie F, Guo Q. The associations between fresh vegetable and fruit consumption and plasma and PET biomarkers in preclinical Alzheimer's disease: A cross-sectional and longitudinal study of Chinese population. J Prev Alzheimers Dis 2025; 12(5): 100076.
99. Jamar G, Ribeiro DA, Pisani LP. High-fat or high-sugar diets as trigger inflammation in the microbiota-gut-brain axis. Crit Rev Food Sci Nutr 2021; 61(5): 836-54.
Chen Z, Han S, Zhou D, Zhou S, Jia G. Effects of oral exposure to titanium dioxide nanoparticles on gut microbiota and gut-associated metabolism in vivo. Nanoscale 2019; 11(46): 22398-412
